Experience

Edmond Lay

    • Shoreline Biosciences Enters Collaboration With BeiGene to Develop Genetically Modified Cell Therapies 


    • Horizon Therapeutics to Acquire Viela Bio 


    • Poseida Therapeutics – $224 Million IPO 


    • Satsuma Pharmaceuticals – $83 Million IPO  


    • Crown Bioscience Enters Merger Agreement With JSR Corporation 


    • Tableau Enters Agreement to Sell to Salesforce for $15.7 Billion 


    • Equillium – $65.4 Million IPO 


    • Jazz Pharmaceuticals Acquires Celator for $1.5 Billion